Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 152 recruiting now full pipeline #8 of 28,707 conditions

Hypertension: full-pipeline trial registry

152 of 472 indexed Hypertension trials are currently recruiting.

Corpus placement: #8 of 28,707 conditions by registered trial count.

472 US clinical trials · 152 currently recruiting · #8 of 28,707 conditions by registered trial count

Hypertension: 472 US clinical trials tracked, 152 recruiting.

Hypertension is the subject of 472 registered US clinical trials on ClinicalTrials.gov, 152 of them currently open to new participants. 65 are in Phase 3-4 (later-stage) and 64 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 15 of these trials.

Enrollment posture brief

Registry condition hypertension

OPEN 152 | RECR 32% | LATE 65 | EARLY 64 | RANK #8 | SPON 15

Nearest open-share peer: Leukemia, Myeloid, Acute (32% recruiting · 31 trials)

Stroke47.8%Non-Small Cell Lung Cancer45.3%Multiple Myeloma37.9%Lung Cancer34%Hypertension (this)32%
Open-enrollment share among volume-matched conditions near Hypertension

Hypertension lists 152 open slots (32% of 472 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hypertension is recruiting below its size-band peers.

    152 of 472 indexed trials (32.2%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Hypertension trials is spread across many organizations.

    Johns Hopkins University accounts for 15 of 472 trials (3.2%). 195 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hypertension enrolment sits around 168 participants.

    Median target enrolment is 168 among the 471 trials that report a genuine target (sentinel values excluded). 170 of those (36.1%) plan for fewer than 100 participants.

  4. Hypertension research is mostly interventional.

    407 interventional and 65 observational studies make up this index (86.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 139Phase 225Phase 337Phase 428

Open and recent trials

472 total, page 10 of 10

COMPLETED Phase 3 20 participants

Diaphragmatic Breathing and Heart Rate Variability Training for Improving Hypertension in Fragile X Associated Tremor/Ataxia

University of California, Davis

NCT03816540

COMPLETED NA 18 participants

Preparing a Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

University of Illinois at Chicago

NCT05796648

COMPLETED Phase 3 17 participants

Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure

Thomas Jefferson University

NCT01499134

COMPLETED NA 17 participants

AVACEN Hand Heating on Fasting Blood Glucose

Jeff Moore

NCT04018586

COMPLETED NA 16 participants

Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care

University of Michigan

NCT02898584

COMPLETED Phase 1 16 participants

L-citrulline Supplementation, Cold Exposure, & Post-Exercise Muscle Ischemia

Florida State University

NCT02104375

COMPLETED Phase 1 15 participants

Physiological Effects of Grape Seed Extract in Diastolic Heart Failure

University of Michigan

NCT01185067

COMPLETED NA 15 participants

Medication Adherence in Hypertension Study

University of Missouri-Columbia

NCT00688350

COMPLETED Phase 1 14 participants

Baxdrostat Bioavailability and Bioequivalence Study

AstraZeneca

NCT05963009

COMPLETED NA 14 participants

Cut Your Pressure Too: The Altadena Barbershop Blood Pressure Study, Phase 2 (Intervention Pilot Study)

Cedars-Sinai Medical Center

NCT02198144

COMPLETED Early Phase 1 12 participants

Pressure Assessment to Improve Outcomes After TAVR: a Registry

North Florida Foundation for Research and Education

NCT03923530

COMPLETED Phase 4 12 participants

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

University of Delaware

NCT00624559

COMPLETED NA 12 participants

FFA Hypertension and Inflammation in Lean and Obese Subjects

Emory University

NCT00721617

COMPLETED Phase 4 11 participants

Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes

Tulane University School of Medicine

NCT02796170

COMPLETED NA 10 participants

Cut Your Blood Pressure 3

Cedars-Sinai Medical Center

NCT03726710

COMPLETED NA 9 participants

Spinal Cord Stimulation to Treat Hypertension

University of Minnesota

NCT02828436

COMPLETED NA 9 participants

Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness

Katherine Vickery

NCT06025721

COMPLETED NA 6 participants

The Mobile Health Platform

Duke University

NCT02099513

COMPLETED Early Phase 1 5 participants

Physiological Study of the Efficacy and Mechanistic Effects of Alcohol Renal Denervation

University of Texas Southwestern Medical Center

NCT03465917

COMPLETED Phase 2 5 participants

Study 3: Minocycline Decreases Microglia Activation

University of Florida

NCT02213575

COMPLETED NA 2 participants

Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril

Scripps Translational Science Institute

NCT01258764

COMPLETED

Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow

US Department of Veterans Affairs

NCT00018304

← Previous Page 10 of 10

Phase Distribution

PhaseTrial count
Phase 1 39
Phase 2 25
Phase 3 37
Phase 4 28

Named interventions

Most-linked intervention names on Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
30 trials
Amlodipine Drug
7 trials
Nebivolol Drug
5 trials
Eplerenone Drug
4 trials
Valsartan Drug
4 trials
Ramipril Drug
4 trials
Usual care Other
4 trials
Saline Drug
4 trials

US sites by state

Facility locations filed on Hypertension trials. A trial with sites in several states counts in each.

California 84 trials
Florida 53 trials
Massachusetts 49 trials
New York 47 trials
Illinois 47 trials
Alabama 43 trials
North Carolina 41 trials
Maryland 40 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hypertension page

472 registered trials, 152 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypertension condition card totals 472 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.